• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

讲座:脑肿瘤相关癫痫中新抗癫痫药物的风险和效益概况。

Lecture: profile of risks and benefits of new antiepileptic drugs in brain tumor-related epilepsy.

机构信息

Center for Tumor-related Epilepsy, Neurology Unit, Department of Neuroscience and Cervical-facial Pathology, National Institute for Cancer Regina Elena, Via Elio Chianesi 53, 00144 Rome, Italy.

出版信息

Neurol Sci. 2011 Nov;32 Suppl 2:S259-62. doi: 10.1007/s10072-011-0801-3.

DOI:10.1007/s10072-011-0801-3
PMID:22012629
Abstract

In patients with brain tumor, seizures are the onset symptom in 20-40% of the patients, while a further 20-45% of the patients will present them during the course of the disease. These data are important when considering the choice of antiepileptic drugs for this particular patient population, because brain tumor-related epilepsy (BTRE) is often drug resistant, has a strong impact on the quality of life and weighs heavily on public health expenditures. In brain tumor patients, the presence of epilepsy is considered as the most important risk factor for long-term disability. For this reason, the problem of the proper administration of medications and their potential side effects is of great importance, because good seizure control can significantly improve the patient's psychological and relational sphere. In these patients, new generation drugs such as gabapentin, lamotrigine, levetiracetam, oxcarbazepine, pregabalin, topiramate, and zonisamide are preferred, because they have fewer drug interactions and cause fewer side effects. Among the recently marketed drugs, lacosamide has demonstrated promising results and should be considered as a possible treatment option. Therefore, it is necessary to develop a customized treatment plan for each patient with BTRE, whose goals are complete seizure control, minimal or no side effects, and elimination of cognitive impairment and/or psychosocial problems.

摘要

在脑肿瘤患者中,20-40%的患者以癫痫发作为首发症状,而另有 20-45%的患者在病程中出现癫痫。这些数据对于考虑为这一特定患者群体选择抗癫痫药物非常重要,因为脑肿瘤相关性癫痫(BTRE)往往具有耐药性,对生活质量有很大影响,并给公共卫生支出带来沉重负担。在脑肿瘤患者中,癫痫的存在被认为是导致长期残疾的最重要的危险因素。出于这个原因,药物的合理管理及其潜在副作用的问题非常重要,因为良好的癫痫控制可以显著改善患者的心理和社交领域。在这些患者中,首选加巴喷丁、拉莫三嗪、左乙拉西坦、奥卡西平、普瑞巴林、托吡酯和唑尼沙胺等新一代药物,因为它们相互作用较少,副作用较少。在最近上市的药物中,拉科酰胺显示出了有前景的结果,应被视为一种可能的治疗选择。因此,有必要为每位 BTRE 患者制定个性化的治疗计划,其目标是完全控制癫痫发作,最小化或无副作用,并消除认知障碍和/或心理社会问题。

相似文献

1
Lecture: profile of risks and benefits of new antiepileptic drugs in brain tumor-related epilepsy.讲座:脑肿瘤相关癫痫中新抗癫痫药物的风险和效益概况。
Neurol Sci. 2011 Nov;32 Suppl 2:S259-62. doi: 10.1007/s10072-011-0801-3.
2
Brain tumor-related epilepsy.脑肿瘤相关性癫痫。
Curr Neuropharmacol. 2012 Jun;10(2):124-33. doi: 10.2174/157015912800604470.
3
Patients with brain tumor-related epilepsy.脑肿瘤相关癫痫患者。
J Neurooncol. 2012 Aug;109(1):1-6. doi: 10.1007/s11060-012-0867-7. Epub 2012 Apr 22.
4
Acute effect of cannabidiol on the activity of various novel antiepileptic drugs in the maximal electroshock- and 6 Hz-induced seizures in mice: Pharmacodynamic and pharmacokinetic studies.大麻二酚对各种新型抗癫痫药物在电休克和 6Hz 诱导的小鼠惊厥中的急性作用:药效学和药代动力学研究。
Neuropharmacology. 2019 Nov 1;158:107733. doi: 10.1016/j.neuropharm.2019.107733. Epub 2019 Aug 1.
5
Quality of life, mood and seizure control in patients with brain tumor related epilepsy treated with lacosamide as add-on therapy: A prospective explorative study with a historical control group.作为附加疗法使用拉科酰胺治疗脑肿瘤相关性癫痫患者的生活质量、情绪及癫痫控制情况:一项设有历史对照组的前瞻性探索性研究
Epilepsy Behav. 2017 Aug;73:83-89. doi: 10.1016/j.yebeh.2017.05.031. Epub 2017 Jun 14.
6
Optimizing antiepileptic drug treatment in tumoral epilepsy.优化肿瘤性癫痫的抗癫痫药物治疗。
Epilepsia. 2013 Dec;54 Suppl 9:97-104. doi: 10.1111/epi.12452.
7
A randomised controlled trial examining the longer-term outcomes of standard versus new antiepileptic drugs. The SANAD trial.一项比较标准抗癫痫药物与新型抗癫痫药物长期疗效的随机对照试验。SANAD试验。
Health Technol Assess. 2007 Oct;11(37):iii-iv, ix-x, 1-134. doi: 10.3310/hta11370.
8
Management of brain tumor-related epilepsy.脑肿瘤相关性癫痫的管理
Neurol India. 2017;65(Supplement):S60-S70. doi: 10.4103/neuroindia.NI_1076_16.
9
[Antiepileptic drugs in North America].[北美地区的抗癫痫药物]
Brain Nerve. 2010 May;62(5):519-26.
10
Issues related to the pharmacological management of patients with brain tumours and epilepsy.与脑肿瘤和癫痫患者的药物治疗相关的问题。
Funct Neurol. 2006 Jan-Mar;21(1):15-9.

引用本文的文献

1
The New Antiepileptic Drugs: Their Neuropharmacology and Clinical Indications.新型抗癫痫药物:其神经药理学与临床适应证
Neurol Med Chir (Tokyo). 2016 May 15;56(5):205-20. doi: 10.2176/nmc.ra.2015-0344. Epub 2016 Mar 2.
2
Seizures in children with dysembryoplastic neuroepithelial tumors of the brain--A review of surgical outcomes across several studies.脑胚胎发育不良性神经上皮肿瘤患儿的癫痫发作——多项研究的手术结果综述
Childs Nerv Syst. 2015 Jun;31(6):847-55. doi: 10.1007/s00381-015-2675-9. Epub 2015 Mar 21.
3
The role of levetiracetam in treatment of seizures in brain tumor patients.

本文引用的文献

1
Lacosamide as add-on in brain tumor-related epilepsy: preliminary report on efficacy and tolerability.拉考酰胺作为脑肿瘤相关癫痫的附加治疗:疗效和耐受性的初步报告。
J Neurol. 2011 Nov;258(11):2100-4. doi: 10.1007/s00415-011-6132-8. Epub 2011 Jun 16.
2
Levetiracetam monotherapy in patients with brain tumor-related epilepsy: seizure control, safety, and quality of life.左乙拉西坦单药治疗脑肿瘤相关癫痫患者:控制癫痫发作、安全性和生活质量。
J Neurooncol. 2011 Aug;104(1):205-14. doi: 10.1007/s11060-010-0460-x. Epub 2010 Nov 25.
3
Epilepsy in brain tumor patients.
左乙拉西坦在脑肿瘤患者癫痫治疗中的作用。
Front Neurol. 2013 Oct 7;4:153. doi: 10.3389/fneur.2013.00153.
脑肿瘤患者的癫痫。
Curr Opin Neurol. 2010 Dec;23(6):603-9. doi: 10.1097/WCO.0b013e32833e996c.
4
Rash in four patients with brain tumor-related epilepsy in monotherapy with oxcarbazepine, during radiotherapy.4例脑肿瘤相关性癫痫患者在放疗期间单药使用奥卡西平治疗时出现皮疹。
J Neurol. 2010 Nov;257(11):1939-40. doi: 10.1007/s00415-010-5637-x. Epub 2010 Jul 8.
5
Seizures in low- and high-grade gliomas: current management and future outlook.低级别和高级别胶质瘤中的癫痫发作:当前的治疗管理和未来展望。
Expert Rev Anticancer Ther. 2010 May;10(5):663-9. doi: 10.1586/era.10.48.
6
Definition of drug resistant epilepsy: consensus proposal by the ad hoc Task Force of the ILAE Commission on Therapeutic Strategies.耐药性癫痫的定义:国际抗癫痫联盟治疗策略特别工作组的共识提案。
Epilepsia. 2010 Jun;51(6):1069-77. doi: 10.1111/j.1528-1167.2009.02397.x. Epub 2009 Nov 3.
7
Correlation of enzyme-inducing anticonvulsant use with outcome of patients with glioblastoma.酶诱导抗惊厥药物的使用与胶质母细胞瘤患者预后的相关性。
Neurology. 2009 Oct 13;73(15):1207-13. doi: 10.1212/WNL.0b013e3181bbfeca.
8
Efficacy and tolerability of zonisamide as add-on in brain tumor-related epilepsy: preliminary report.唑尼沙胺作为脑肿瘤相关性癫痫附加治疗的疗效和耐受性:初步报告。
Acta Neurol Scand. 2009 Sep;120(3):210-2. doi: 10.1111/j.1600-0404.2009.01226.x.
9
Reversible erectile dysfunction in a patient with brain tumor-related epilepsy in therapy with zonisamide in add-on.合并佐尼莫司胺治疗的脑瘤相关性癫痫患者出现可逆性勃起功能障碍。
J Sex Med. 2011 Dec;8(12):3515-7. doi: 10.1111/j.1743-6109.2009.01373.x. Epub 2009 Jun 29.
10
Efficacy of anti-epileptic drugs in patients with gliomas and seizures.抗癫痫药物对胶质瘤伴癫痫患者的疗效。
J Neurol. 2009 Sep;256(9):1519-26. doi: 10.1007/s00415-009-5156-9. Epub 2009 May 12.